4.6 Article

Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?

Related references

Note: Only part of the references are listed.
Review Oncology

Accuracy of MRI-guided Versus Systematic Prostate Biopsy in Patients Under Active Surveillance: A Systematic Review and Meta-analysis

Willy Baccaglini et al.

Summary: This meta-analysis compared the accuracy of upgrading to clinically significant prostate cancer between MRI-TB and SB in low-risk PCa patients in active surveillance. The results showed that MRI-TB had better performance compared to SB. Therefore, using MRI-TB alone may be preferable in patients with low-risk PCa in active surveillance.

CLINICAL GENITOURINARY CANCER (2021)

Article Urology & Nephrology

Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?

Myong Kim et al.

Summary: This study identified age, PSA density, prior biopsy history, and PI-RADS score as significant predictors for the absence of clinically significant prostate cancer in MRI fusion-targeted biopsies. Patients with low PSA density may safely evade MRIFTB, while those with high PSA density need to be more cautious.

WORLD JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

Ugo Falagario et al.

Summary: The developed nomogram based on MRI volumetric parameters and clinical information has the potential to assist in determining when SBx should be performed in men with suspicious prostate MRI, providing a potential benefit in addition to TBx.

WORLD JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies

Magdalena Goertz et al.

Summary: Including prostate-specific antigen density (PSAD) < 0.1 ng/ml/ml in the strategy could reduce prostate biopsies by 43% while excluding significant prostate cancer.

EUROPEAN UROLOGY FOCUS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance

Joseba Salguero et al.

Summary: Performing mpMRI before confirmatory prostate biopsy can help assess the risk of reclassification in patients as well as the risk of progression to active treatment during the follow-up period.

KOREAN JOURNAL OF RADIOLOGY (2021)

Review Oncology

Personalized strategies in population screening for prostate cancer

Sebastiaan Remmers et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Urology & Nephrology

Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions

Bashir Al Hussein Al Awamlh et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Article Andrology

Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy

Shuo Yang et al.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)

Review Pharmacology & Pharmacy

Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer

Maria Frantzi et al.

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2020)

Article Urology & Nephrology

New Approach to Guide Target Prostate Biopsy: Technique and Initial Experience

Enrique Gomez Gomez et al.

UROLOGY (2018)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Urology & Nephrology

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

Donna P. Ankerst et al.

EUROPEAN UROLOGY (2018)

Article Medicine, General & Internal

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

V Kasivisvanathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI

Mrishta Brizmohun Appayya et al.

BRITISH JOURNAL OF RADIOLOGY (2018)

Article Medicine, General & Internal

Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

M. Minhaj Siddiqui et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)